| Literature DB >> 24179622 |
Kristy Appelhans1, Raushanah Najeeullah, Vasilios Frankos.
Abstract
The authors of the subject article by Senadhi et al have misrepresented the safety and regulatory status of Herbalife's products. While we are very concerned with the unwarranted and unfavorable publicity that the inaccuracies listed could generate for Herbalife, we would welcome any inquiries that these authors may have to better clarify our commitment to the safety and quality of our products as has been demonstrated in part by our ability to establish positive relationships with regulatory authorities worldwide through continued cooperation and compliance. This letter clarifies the misinformation presented about Herbalife in the subject article.Keywords: Dietary supplements; Drug-induced liver injury; Hepatitis; Herbal; Herbalife
Year: 2013 PMID: 24179622 PMCID: PMC3812465 DOI: 10.4254/wjh.v5.i10.601
Source DB: PubMed Journal: World J Hepatol